22 Matching Annotations
  1. Dec 2024
  2. Jun 2024
  3. Feb 2023
    1. Expert Opinionon theCurrent State of U.S. Surveillance Law and AuthoritiesfromProf. Stephen I. Vladeck,University of Texas School of Law

      Vladeck Opinion

    2. section 702 is compulsory in the sense that, when the United States hasissued a directive to an electronic communication service provider that is authorizedby its annual certification to the FISA Court under section 702, the provider musteither (1) comply; or (2) challenge the directive in the FISA Court

      FISA 702 Orders are compulsory - you either comply, or challenge.

    1. Such instruments should, forexample, address the measures to be taken in case of conflict of laws between third country legislationand the GDPR and in the event of third country requests for disclosure of data.

      But how? in the DPA? The point of the transfer mechanism (e.g., SCCs / BCRs) is to be standard. You can't modify them.

      This sounds like a thing the EDPB/EC need to do not controllers/processors directly.

  4. Apr 2021
    1. Quelques textesArticle R. 421-46 du code de l’éducation«Le comité d'éducation à la santé et à la citoyenneté réunit, sous la présidence du chefd'établissement, les personnels d'éducation, sociaux et de santé de l'établissement et desreprésentants des personnels enseignants, des parents et des élèves, désignés par le chefd'établissement sur proposition des membres du conseil d'administration appartenant à leurscatégories respectives, ainsi que les représentants de la commune et de la collectivitéterritoriale de rattachement au sein de ce conseil. En fonction des sujets traités, il peutassocier à ses travaux toute personne dont il estime l'avis utile»
  5. Mar 2021
    1. Results for individual PALB2 variants were normalized relative to WT-PALB2 and the p.Tyr551ter (p.Y551X) truncating variant on a 1:5 scale with the fold change in GFP-positive cells for WT set at 5.0 and fold change GFP-positive cells for p.Y551X set at 1.0. The p.L24S (c.71T>C), p.L35P (c.104T>C), p.I944N (c.2831T>A), and p.L1070P (c.3209T>C) variants and all protein-truncating frame-shift and deletion variants tested were deficient in HDR activity, with normalized fold change <2.0 (approximately 40% activity) (Fig. 1a).

      AssayResult: 6.2

      AssayResultAssertion: Normal

      StandardErrorMean: 1.39

    2. A total of 84 PALB2 patient-derived missense variants reported in ClinVar, COSMIC, and the PALB2 LOVD database were selected

      HGVS: NM_024675.3:c.2873A>C p.(Gln958Pro)

    1. Source Data

      AssayResult: 37.28

      AssayResultAssertion: Not reported

      ReplicateCount: 2

      StandardErrorMean: 11.28

      Comment: Exact values reported in “Source Data” file.

    2. Source Data

      AssayResult: 10.42

      AssayResultAssertion: Abnormal

      ReplicateCount: 2

      StandardErrorMean: 0.01

      Comment: Exact values reported in “Source Data” file.

    3. Source Data

      AssayResult: 10.59

      AssayResultAssertion: Abnormal

      ReplicateCount: 2

      StandardDeviation: 0.6

      StandardErrorMean: 0.43

      Comment: Exact values reported in “Source Data” file.

    4. We, therefore, analyzed the effect of 48 PALB2 VUS (Fig. 2a, blue) and one synthetic missense variant (p.A1025R) (Fig. 2a, purple)29 on PALB2 function in HR.

      HGVS: NM_024675.3:c.3128G>A p.(G1043D)

    1. Most Suspected Brugada Syndrome Variants Had (Partial) Loss of Function

      AssayResult: 1.6

      AssayResultAssertion: Abnormal

      ReplicateCount: 15

      StandardErrorMean: 0.7

      Comment: This variant had loss of function of peak current (<10% of wildtype), therefore it was considered abnormal (in vitro features consistent with Brugada Syndrome Type 1). (Personal communication: A. Glazer)

    2. we selected 73 previously unstudied variants: 63 suspected Brugada syndrome variants and 10 suspected benign variants

      HGVS: NM_198056.2:c.4037T>C p.(Leu1346Pro)

  6. Feb 2021
    1. We analysed a total of 82 blood samples derived from 77 individuals (online supplemental table 3). These 77 individuals corresponded either to new index cases suspected to harbour a pathogenic TP53 variant or to relatives of index cases harbouring TP53 variants.

      HGVS: NM_000546.5:c.844C>T p.(Arg282Trp)

    2. Supplemental material

      AssayResult: 98

      AssayResultAssertion: Normal

      Comment: See Table S3 for details

    3. Supplemental material

      AssayResult: 102

      AssayResultAssertion: Normal

      Comment: See Table S3 for details

    4. Supplemental material

      AssayResult: 5

      AssayResultAssertion: Abnormal

      Comment: See Table S3 for details

    5. Supplemental material

      AssayResult: 4.8

      AssayResultAssertion: Abnormal

      Comment: See Table S3 for details

    6. Supplemental material

      AssayResult: 83

      AssayResultAssertion: Normal

      Comment: See Table S2 for details

    7. Supplemental material

      AssayResult: 5.5

      AssayResultAssertion: Abnormal

      Comment: See Table S2 for details

  7. Feb 2019